Study on PK/PD of immune checkpoint inhibitors according to differential dosage in elderly non-small cell lung cancer patients
Not Applicable
Recruiting
- Conditions
- relapse or advanced non-small cell lung cancer
- Registration Number
- JPRN-UMIN000052618
- Lead Sponsor
- ational Cancer Center Hospital, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who cannot give consent for specimen collection. 2) Patients who are judged by the principal investigator or the physician in charge to be inappropriate as subjects for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method